Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity
Crossref DOI link: https://doi.org/10.1038/srep10172
Published Online: 2015-05-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Wei
Bai, Jia-Ke
Li, Hong-Mei
Chen, Tao
Tang, Ya-Jie
Text and Data Mining valid from 2015-05-11
Version of Record valid from 2015-05-11
Article History
Received: 20 November 2014
Accepted: 1 April 2015
First Online: 11 May 2015
Competing interests
: The authors declare no competing financial interests.